CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0106

YK11

Filed under Oral Tablets. The bureau holds 50 laboratory returns for this compound from 17 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

17 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
HomopeptideCASE #VI-2026-0760A510.09.910.024 May 202624 May 2026
Tianjin Finder Chemical TFCCASE #VI-2026-0693A410.010.010.014 Nov 202516 Apr 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A79.48.410.024 May 202624 May 2026
Xianhong Tong XHT PeptidesCASE #VI-2026-0997X18.68.68.613 Jun 202513 Jun 2025
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A58.57.69.124 May 202624 May 2026
Shandong Aishi BiotechnologyCASE #VI-2026-0308X18.18.18.114 Jan 202514 Jan 2025
Glbiochem (Shanghai)CASE #VI-2026-0704A38.07.88.323 May 202623 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A27.97.48.324 May 202624 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A77.86.210.025 May 202625 May 2026
Pharma Grade PeptidesCASE #VI-2026-0208X17.77.77.725 Apr 202525 Apr 2025
Alpha-GenCASE #VI-2026-0905X37.15.010.09 Jun 202526 Jan 2026
Kits4lessCASE #VI-2026-0744X16.96.96.920 Jun 202520 Jun 2025
Skye PeptidesCASE #VI-2026-0451X46.85.09.314 Jan 202523 May 2026
LSPLCASE #VI-2026-0523X36.75.78.725 Apr 202526 Jan 2026
Shanghai OuDaXin New Material Technology CenterCASE #VI-2026-0498X14.74.74.716 Mar 202516 Mar 2025
Peptide GurusCASE #VI-2026-0854X24.04.04.06 May 202525 May 2026
NuLife PeptidesCASE #VI-2026-0980X10.00.00.016 Mar 202516 Mar 2025

Open any subject to view the batch-level evidence for YK11 alone.